| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Valantine Hannah is a Director at CareDx, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 8,671 | $72.00 | $624,312.00 | -53.7% | - | - | |
| Nov 12, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 25,484 | $66.07 | $1,683,727.88 | -77.3% | +9.4% | - | |
| Jun 26, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 4,707 | $44.05 | $207,327.26 | -19.7% | +12.3% | - | |
| Jun 18, 2025 | CDNA Caredx, Inc. | Director | Sell | 10,570 | $19.16 | $202,565.59 | -21.3% | -25.5% | - | |
| Jun 10, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 4,292 | $40.00 | $171,680.00 | -70.9% | +35.4% | - | |
| Mar 6, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 12,875 | $32.58 | $419,499.69 | -87.9% | +18.0% | +102.8% | |
| Feb 15, 2024 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 2,915 | $37.75 | $110,041.25 | -62.3% | -23.6% | -11.0% | |
| Jan 16, 2024 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 2,915 | $37.97 | $110,682.55 | -62.3% | -31.4% | -6.9% | |
| Dec 15, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 2,915 | $36.12 | $105,289.80 | -62.3% | -30.5% | -30.2% | |
| Nov 15, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 2,915 | $30.00 | $87,450.00 | -62.3% | +13.7% | -18.3% |